Huaying Huang

1PUBLICATIONS
3CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 17, 2021
Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report.

Yuanyang Zhao, Yuxing Chen, Huaying Huang

Pageof 1

Frequent Collaborators

1 joint publications

Yuanyang Zhao

1 joint publications

Yuxing Chen

1 joint publications

Hao Ding